NFYB and cancer: Although the number of carriers of Hap3 and Hap4 were not sufficient to establish a clear haplotype-cancer phenotype association, we did observe a pattern whereby Hap4 carriers more closely resembled classical LFS, including breast cancers, sarcomas, and multiple primary tumors.